Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
heparin/možganska kap
Povezava se shrani v odložišče
Stran 1 iz 2375 rezultatov
Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
The risk of intracerebral hemorrhage in systemic thrombolysis for acute ischemic stroke after acetylsalicylic acid (ASA) pretreatment or with subsequent heparin is controversially discussed.
METHODS
300 consecutive stroke patients were treated with recombinant tissue-type plasminogen
Reduced Ischemic Lesion Growth with Heparin in Acute Ischemic Stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Intravenous heparin for the treatment of intraluminal thrombus in patients with acute ischemic stroke: a case series.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
Current American Stroke Association/American Heart Association recommendations on the management of acute ischemic stroke do not recommend the early use of heparin because of an increased risk of bleeding complications. However, for select patients, such as those with strokes associated
Use of Heparin in Acute Ischemic Stroke: Is There Still a Role?
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Heparin has long been a contested therapy in acute ischemic stroke (AIS). In current practice, heparin is considered on a case-by-case basis, but there is no consensus as to the appropriate timing of anticoagulation or for which ischemic stroke subtypes heparin may be beneficial. To provide better
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Low molecular weight heparins and heparinoids may be associated with lower risks of haemorrhage and more powerful antithrombotic effects than standard unfractionated heparin.
OBJECTIVE
The objective of this review was to compare the effects of low molecular weight heparins or heparinoids
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Low molecular weight heparins and heparinoids may be associated with lower risks of haemorrhage and more powerful antithrombotic effects than standard unfractionated heparin.
OBJECTIVE
The objective of this review was to compare the effects of low molecular weight heparins or heparinoids
Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The numerous large-scale randomized clinical trials performed during the last decade on either unfractionated heparin, or low molecular weight heparin have not been able to demonstrate undisputed benefits in patients with acute ischemic stroke, compared with no treatment or aspirin. However, a large
Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
A lot of clinicians use heparin in patients with posterior circulation stroke. Frequency and risk factors of symptomatic intracerebral hematoma (ICH) in posterior circulation infarct patients anticoagulated with unfractionated heparin are not known.
METHODS
To determine the incidence and
[Ischemic stroke and heparin-induced thrombocytopenia].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Immune-mediated heparin-induced thrombocytopenia (HIT) is a rare but serious side effect of heparin therapy which presents various thromboembolic events associated with high mortality and morbidity. There have been few reports about the prevalence of HIT in acute ischemic stroke, which our
[Heparin and ischemic stroke].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
In absence of careful controlled trials, heparin therapy of ischemic stroke is based today on the clinical experience and personal belief of the physicians. Moreover, the incomplete knowledge of physiopathogenesis of ischemic stroke adds further confusion on those nosographic conditions treatable
Aspirin or heparin in acute stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Acute stroke treatment using aspirin and/or heparin was studied in the International Stroke Trial (IST) and Chinese Acute Stroke Trial (CAST) which randomised over 40,000 patients altogether. Combining the results demonstrated that aspirin (150-300 mg) given within 48 h of the onset of stroke
Subcutaneous Heparin Therapy for Patients with Cancer-Associated Stroke.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Anticoagulation therapy, particularly subcutaneous heparin therapy, is recommended for cancer-associated thrombosis. However, not starting or discontinuing anticoagulation was not rare. The aim of the present study was to examine the practical issues related to anticoagulation therapy and
Heparin during endovascular stroke treatment seems safe.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Heparin in acute ischemic stroke revisited.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The evidence gathered in clinical trials of low molecular weight heparins (LMWHs) or with unfractionated heparin (UH) given subcutaneously at low or medium doses to patients with acute stroke cannot be extrapolated to the insufficiently tested effects of intravenous, weight-adjusted UH. Recent small
Acute ischemic stroke and heparin treatments.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Several case-control studies have reported enhanced platelet activity, hypercoagulation and/or reduced fibrinolytic activity in patients with acute ischemic stroke. However, results of these studies are conflicting and do not allow to make recommendations regarding heparin treatment. The aim of
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
